Chemours Faces Investor Suit Over Alleged Exec Misconduct
Chemical company The Chemours Co. and four of its current and former executives face claims they hurt investors by manipulating a certain financial metric so the executives might receive greater compensation...To view the full article, register now.
Already a subscriber? Click here to view full article